Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPOPROSTENOL vs ERENUMAB-AOOE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EPOPROSTENOL vs ERENUMAB-AOOE: Safety Overview

Metric EPOPROSTENOL ERENUMAB-AOOE
Total FAERS Reports 13,322 50,133
Deaths Reported 2,713 1,935
Death Rate 20.4% 3.9%
Hospitalizations 8,838 3,054
Average Patient Age 49.9 yrs 50.2 yrs
% Female Patients 78.1% 86.2%
FDA Approval Date Apr 23, 2008 N/A
Manufacturer Mylan Institutional LLC N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued Prescription